Sanofi has announced an
agreement with Apeiron Biologics
and Evotec to develop “small
molecule-based immuno-oncology
therapies” which will target sold
and haematological cancers by
enhancing the ability of the human
immune system to fight tumours.
Sanofi will fund the research
for two years and have
responsibility for all development,
commercialisation, regulatory and
manufacturing of any products
which result from the project.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Aug 15
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.